Mitogen‐activated protein kinase activity drives cell trajectories in colorectal cancer
2021 · EMBO Molecular Medicine · 194 citations
https://doi.org/10.15252/emmm.202114123
T
Thomas Sell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
535
Citations
9
h-index
9
i10-index
Thomas Sell is an academic researcher from Humboldt-Universität zu Berlin. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research. The author has an h-index of 9, co-authored 23 publications.
ORCID: 0000-0002-5138-3967Papers by this author
worksCell type-dependent differential activation of ERK by oncogenic KRAS in colon cancer and intestinal epithelium
2019 · Nature Communications · 98 citations
https://doi.org/10.1038/s41467-019-10954-y
Protonophore properties of hyperforin are essential for its pharmacological activity
2014 · Scientific Reports · 59 citations
https://doi.org/10.1038/srep07500
Conserved Gating Elements in TRPC4 and TRPC5 Channels
2013 · Journal of Biological Chemistry · 54 citations
https://doi.org/10.1074/jbc.m113.478305
Triple Targeting of HER Receptors Overcomes Heregulin-mediated Resistance to EGFR Blockade in Colorectal Cancer
2022 · Molecular Cancer Therapeutics · 15 citations
https://doi.org/10.1158/1535-7163.mct-21-0818
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat